Market Update for January 2021
After equity markets finished December strongly, they took a breather in January. Bond markets didn’t do much better.
Guiding you along your financial journey
After equity markets finished December strongly, they took a breather in January. Bond markets didn’t do much better.
In our last post, we discussed in-kind contributions. Many investors, who are otherwise unable to make a TFSA and RRSP contributions, may be able to contribute existing non-registered investments to their RRSP accounts, thereby getting a tax deduction in the process. However, it’s important to be careful of a couple of potential tax traps when making in-kind contributions – superficial […]
December was a good month for stock and bond markets, capping off an odd and volatile year. When looking at the performance for the year overall, it turned out to be an average year despite the sharp drop and panic in March.
While many investors have good intentions of making TFSA and RRSP contributions, the unfortunate reality is that the cash required to make a meaningful contribution isn’t always available. What can you do? If you want to make a contribution to your TFSA and RRSP this year, but don’t have the cash available, you can use some of the investments in […]
Welcome to 2021! We all know how challenging it can be to stay on top of ever-changing facts and figures in the field of personal finance. To help kick-off the New Year, we have compiled a short list of key 2021 facts and figures to keep in mind for the new year. TFSA Limit The 2021 TFSA limit remains at $6,000, […]
While the deadline for filing your taxes is still months away, the 2020 year-end is only weeks away, and most strategies discussed in this post would have to be implemented before December 31st in order to effective for the 2020 tax year. Let’s take a look at our top 5 tax saving tips and strategies. Make your RESP contributions. […]
November was a strong month for stock and bond markets following announcements of positive test results for COVID-19 vaccines.
October was a down month for nearly all equity market indices we track, with emerging markets being one of the few positives.